MACROGENICS, INC. Proceeds from Common Stock Issued
MACROGENICS, INC. (MGNX) reported Proceeds from Common Stock Issued of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-03-09
- MACROGENICS, INC. proceeds from issuance of common stock for the quarter ending 2024-12-31 was $0.00.
- MACROGENICS, INC. proceeds from issuance of common stock for the quarter ending 2024-09-30 was $0.00.
- MACROGENICS, INC. proceeds from issuance of common stock for the quarter ending 2024-06-30 was $0.00.
- MACROGENICS, INC. proceeds from issuance of common stock for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- MACROGENICS, INC. proceeds from issuance of common stock for fiscal 2025 was $0.00.
- MACROGENICS, INC. proceeds from issuance of common stock for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- MACROGENICS, INC. proceeds from issuance of common stock for fiscal 2023 was $616.00K, a 43.23% decline from fiscal 2022.
- MACROGENICS, INC. proceeds from issuance of common stock for fiscal 2022 was $1.08M, a 99.08% decline from fiscal 2021.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 3 month as first filed | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 6 month as first filed | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-09 | ||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 10-K · filed 2026-03-09 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $0.00 10-Q · filed 2024-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $616.00K 10-K · filed 2026-03-09 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $616.00K 10-Q · filed 2024-11-05 | $1.70M derived: sum of 4 quarters · filed 2025-03-20 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $616.00K 10-Q · filed 2024-08-06 | $1.70M derived: sum of 3 quarters · filed 2025-03-20 | $1.70M derived: sum of 4 quarters · filed 2025-03-20 | |||
| 2023-03-31 | $616.00K 10-Q · filed 2024-05-09 | $1.70M derived: sum of 2 quarters · filed 2025-03-20 | $1.70M derived: sum of 3 quarters · filed 2025-03-20 | $1.70M derived: sum of 4 quarters · filed 2025-03-20 | |||
| 2022-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $1.08M derived: sum of 2 quarters · filed 2025-03-20 | $1.08M derived: sum of 3 quarters · filed 2025-03-20 | $1.08M 10-K · filed 2025-03-20 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $0.00 derived: sum of 2 quarters · filed 2023-11-06 | $0.00 10-Q · filed 2023-11-06 | $0.00 derived: sum of 4 quarters · filed 2024-03-07 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-03-07 | $19.62M derived: sum of 4 quarters · filed 2024-03-07 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-03-07 | $19.62M derived: sum of 3 quarters · filed 2024-03-07 | $19.62M derived: sum of 4 quarters · filed 2024-03-07 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $19.62M derived: sum of 2 quarters · filed 2024-03-07 | $19.62M derived: sum of 3 quarters · filed 2024-03-07 | $117.82M 10-K · filed 2024-03-07 | |||
| 2021-09-30 | $19.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $19.62M derived: sum of 2 quarters · filed 2022-11-03 | $117.82M 10-Q · filed 2022-11-03 | $117.78M derived: sum of 4 quarters · filed 2023-03-15 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $98.20M 10-Q · filed 2022-08-08 | $98.16M derived: sum of 3 quarters · filed 2023-03-15 | $172.14M derived: sum of 4 quarters · filed 2023-03-15 | |||
| 2021-03-31 | $98.20M 10-Q · filed 2022-05-03 | $98.16M derived: sum of 2 quarters · filed 2023-03-15 | $172.14M derived: sum of 3 quarters · filed 2023-03-15 | $268.66M derived: sum of 4 quarters · filed 2023-03-15 | |||
| 2020-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $73.94M derived: sum of 2 quarters · filed 2023-03-15 | $170.46M derived: sum of 3 quarters · filed 2023-03-15 | $170.46M 10-K · filed 2023-03-15 | |||
| 2020-09-30 | $73.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $170.49M derived: sum of 2 quarters · filed 2021-11-02 | $170.49M 10-Q · filed 2021-11-02 | $170.49M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $96.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $96.51M 10-Q · filed 2021-07-29 | $96.51M derived: sum of 3 quarters · filed 2022-02-24 | $96.51M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-04-29 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $0.00 derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $118.66M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $0.00 derived: sum of 2 quarters · filed 2020-11-04 | $118.66M 10-Q · filed 2020-11-04 | $118.66M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $118.66M 10-Q · filed 2020-07-31 | $118.66M derived: sum of 3 quarters · filed 2021-02-25 | $118.66M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | $118.66M 10-Q · filed 2020-05-05 | $118.66M derived: sum of 2 quarters · filed 2021-02-25 | $118.66M derived: sum of 3 quarters · filed 2021-02-25 | $221.92M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $103.26M derived: sum of 3 quarters · filed 2021-02-25 | $103.26M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $103.26M derived: sum of 2 quarters · filed 2019-11-06 | $103.26M 10-Q · filed 2019-11-06 | $103.21M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | $103.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $103.26M 10-Q · filed 2019-07-31 | $103.21M derived: sum of 3 quarters · filed 2020-02-25 | $104.33M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-01 | -$50.00K derived: sum of 2 quarters · filed 2020-02-25 | $1.07M derived: sum of 3 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.07M derived: sum of 2 quarters · filed 2020-02-25 | $34.24M 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $34.29M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | $33.17M 10-Q · filed 2018-08-07 | ||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 derived: sum of 3 quarters · filed 2019-02-26 | $0.00 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $0.00 10-Q · filed 2017-11-08 | $0.00 derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $0.00 10-Q · filed 2017-08-02 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $140.78M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-04 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $140.78M derived: sum of 3 quarters · filed 2018-02-27 | $140.78M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $140.78M derived: sum of 2 quarters · filed 2018-02-27 | $140.78M derived: sum of 3 quarters · filed 2018-02-27 | $203.47M 10-K · filed 2018-02-27 | |||
| 2015-09-30 | $140.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $140.78M derived: sum of 2 quarters · filed 2016-11-02 | $203.47M 10-Q · filed 2016-11-02 | $203.45M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $62.69M 10-Q · filed 2016-08-03 | $62.67M derived: sum of 3 quarters · filed 2017-02-28 | $62.67M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | $62.69M 10-Q · filed 2016-05-04 | $62.67M derived: sum of 2 quarters · filed 2017-02-28 | $62.67M derived: sum of 3 quarters · filed 2017-02-28 | $62.67M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$17.00K derived: sum of 2 quarters · filed 2017-02-28 | -$17.00K derived: sum of 3 quarters · filed 2017-02-28 | $76.72M 10-K · filed 2017-02-28 | |||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $0.00 derived: sum of 2 quarters · filed 2015-11-04 | $76.73M 10-Q · filed 2015-11-04 | $160.65M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $76.73M 10-Q · filed 2015-08-05 | $77.04M 10-Q · filed 2014-08-05 | $160.65M derived: sum of 3 quarters · filed 2016-02-29 | $160.79M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | $76.73M 10-Q · filed 2015-05-06 | $76.80M 10-Q · filed 2014-05-06 | $160.65M derived: sum of 2 quarters · filed 2016-02-29 | $160.79M derived: sum of 3 quarters · filed 2016-02-29 | $161.45M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $83.92M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $84.06M derived: sum of 2 quarters · filed 2016-02-29 | $84.71M derived: sum of 3 quarters · filed 2016-02-29 | $84.77M 10-K · filed 2016-02-29 | $85.87M 10-K · filed 2014-03-20 | ||
| 2013-09-30 | $142.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $794.65K derived: sum of 2 quarters · filed 2014-08-05 | $851.18K 10-Q · filed 2013-11-12 | $853.70K derived: sum of 4 quarters · filed 2014-08-05 | |||
| 2013-06-30 | $652.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $709.00K 10-Q · filed 2014-08-05 | $711.52K derived: sum of 3 quarters · filed 2014-08-05 | ||||
| 2013-03-31 | $56.53K 10-Q · filed 2014-05-06 | $59.05K derived: sum of 2 quarters · filed 2014-05-06 | |||||
| 2012-12-31 | $2.52K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $46.83K 10-K · filed 2014-03-20 | |||||
| 2012-09-30 | $44.31K 10-Q · filed 2013-11-12 | ||||||
| 2011-12-31 | $70.40K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |